Valuation: EMV Capital plc

Market Cap 11.75M 15.64M 14.03M 12.97M 21.95M 1.49B 22.21M 155M 61.77M 779M 58.67M 57.44M 2.47B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 12.36M 16.45M 14.76M 13.65M 23.09M 1.57B 23.37M 163M 64.99M 820M 61.73M 60.43M 2.6B EV / Sales 2026 *
3.91x
EV / Sales 2027 * 3.72x
Free-Float
52.8%
Yield 2026 *
-
Yield 2027 * -
1 week-1.18%
Current month-6.67%
1 month-6.67%
3 months-21.50%
6 months-8.70%
Current year-26.32%
1 week 40
Extreme 40
43
1 month 40
Extreme 40
49
Current year 40
Extreme 40
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
125.6
10 years 9.75
Extreme 9.75
770
Manager TitleAgeSince
Chief Executive Officer 50 01/05/2020
Director of Finance/CFO 45 01/12/2025
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 14/10/2019
Director/Board Member 47 09/12/2022
Chairman 61 01/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
8/1/26 Buy 7,000 0.0250%
8/1/26 Sell 7,000 0.0250%
19/12/25 Sell

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.18%-8.70%-24.32% 15.64M
+1.92%+0.72%+2.93%+93.60% 179B
+1.80%+1.95%+27.91%+84.10% 142B
+0.68%+1.88%+37.01%+256.93% 99.99B
+0.31%+6.84%-22.83%+30.63% 93.62B
+0.71%+2.20%-18.69%+99.64% 85.59B
+1.22%+3.53%-22.86%+71.98% 83.52B
+0.87%+2.55%-13.73%+64.97% 75.45B
-0.10%+2.30%-8.20%+42.20% 67B
+1.55%+2.72%+46.23%+175.77% 47.35B
Average +0.90%+1.27%+1.91%+89.55% 87.4B
Weighted average by Cap. +1.13%+1.80%+3.61%+100.55%

Financials

2026 *2027 *
Net sales 3.16M 4.2M 3.77M 3.49M 5.9M 400M 5.97M 41.7M 16.61M 210M 15.78M 15.44M 665M 3.45M 4.6M 4.12M 3.81M 6.45M 438M 6.53M 45.58M 18.15M 229M 17.24M 16.88M 727M
Net income - -
Net Debt 613K 815K 732K 676K 1.14M 77.66M 1.16M 8.09M 3.22M 40.64M 3.06M 3M 129M 1.11M 1.48M 1.33M 1.23M 2.07M 141M 2.1M 14.65M 5.83M 73.6M 5.54M 5.43M 234M
Projected Income Statement - Annual - EMV Capital plc
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Employees
21
Date Price Change Volume
29/10/26 GBX 42.00 0.00% 0
28/10/26 GBX 42.00 0.00% 4,697
27/10/26 GBX 42.00 +2.44% 27,797
26/10/26 GBX 41.00 -3.53% 12,404
23/10/26 GBX 42.50 0.00% 5,107
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4200GBP
Average target price
1.280GBP
Spread / Average Target
+204.76%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - EMV Capital plc
  1. Stock Market
  2. Stocks
  3. EMVC Stock